Matthias John

Matthias John is a seasoned professional in the field of molecular biology and biochemistry with extensive experience in analytical development and nucleic acid therapies. Currently serving as Senior Director of Analytical Development at Abata Therapeutics since June 2021, Matthias previously held the position of Head of mRNA Gene Editing at GeneLeap Biotech, where expertise in therapeutic mRNA techniques was introduced. As an independent consulting scientist, Matthias provided valuable guidance on the manufacturing and delivery of nucleic acid therapeutics. Prior roles include Research Fellow and Head of Platform Operations at CRISPR Therapeutics and various senior research positions at Moderna Therapeutics. Matthias holds a Post-Doc degree from Harvard Medical School and a Ph.D. from Université Louis Pasteur (Strasbourg I).